Profile data is unavailable for this security.
About the company
European Institute of Science AB (EURIS) is a Sweden-based commercial research center. The Company, through its wholly owned subsidiary, ScienceHouse Lund AB is engaged in the research, development, manufacturing, sales and marketing of medical technology, health care, cosmetics and personal care, biotechnology, energy, education and entertainment products and methods. Additionally, it is engaged in the investment in high-technology companies, as well as in leasing and management of properties. As of December 31, 2011, the Company’s investments and project royalties included LifeAssays AB (publ), Biotech-IgG AB and Implementa Hebe AB (publ). The Company’s products include liquid chromatography equipment for affinity purification of proteins and antibodies, and a range of products obtained from pooled human or animal plasma.
- Revenue in SEK (TTM)764.87k
- Net income in SEK-2.65m
- Incorporated1990
- Employees2.00
- LocationEuropean Institute of Science ABIdeongatan 1ALUND 223 70SwedenSWE
- Phone+46 462862230
- Fax+46 46129879
- Websitehttps://www.euris.org/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neovacs SA | 6.07m | -99.49m | 1.15m | 22.00 | -- | 0.00 | -- | 0.1889 | -30,639.66 | -30,639.66 | 1.52 | 138.89 | 0.0099 | -- | 1.84 | 24,245.91 | -16.21 | -24.42 | -17.66 | -28.28 | 5.50 | -232.13 | -1,639.16 | -6,444.71 | -- | -- | 0.0131 | -- | 47,954.95 | -- | -146.40 | -- | 82.72 | -- |
European Institute of Science AB | 764.87k | -2.65m | 1.58m | 2.00 | -- | 2.38 | -- | 2.07 | -3.95 | -3.95 | 1.13 | 1.23 | 0.3042 | 1.80 | 5.71 | 382,435.00 | -105.50 | -93.04 | -115.57 | -103.14 | 54.58 | 66.99 | -346.76 | -518.86 | 8.19 | -- | 0.00 | -- | 13.66 | 8.54 | 0.3974 | -- | -- | -- |
Paion AG | -1.14tn | -1.14tn | 1.79m | 64.00 | -- | -- | -- | -- | -- | -- | -- | -0.4074 | -- | -- | -- | -- | -- | -24.86 | -- | -34.32 | -- | -- | -- | -52.40 | 0.5078 | -- | 1.17 | -- | 366.42 | 41.74 | 97.34 | -- | 129.37 | -- |
Theravet SA | -1.14tn | -1.14tn | 4.20m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Oxurion NV | 955.83k | -129.41m | 4.88m | 20.00 | -- | -- | -- | 5.11 | -32.56 | -32.56 | 0.1116 | -12.06 | 0.0103 | -- | 0.0346 | 4,200.00 | -138.93 | -84.30 | -- | -118.70 | -25.00 | 48.90 | -13,539.29 | -2,008.99 | -- | -1.81 | -- | -- | -55.80 | -45.20 | 40.13 | -- | -65.17 | -- |
Epigenomics AG | -1.14tn | -1.14tn | 5.01m | 4.00 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -68.91 | -- | -80.04 | -- | 12.05 | -- | -562.29 | -- | -- | 1.00 | -- | -62.27 | -26.04 | 74.21 | -- | -50.98 | -- |